Aptar Pharma Boosts Manufacturing Capacity in North America
Aptar Pharma, a division of AptarGroup, Inc. and a recognized leader in drug delivery and consumer product technologies, has proudly announced a significant expansion at its facility located in Congers, New York. This enhancement directly addresses the growing need for effective prescription and consumer healthcare drug delivery systems throughout North America.
Embracing the Future
During a recent ceremony, Aptar’s President and CEO, Stephan Tanda, along with the executive committee, underscored the importance of this expansion. They were joined by employees, government officials, and valued customers to celebrate the growth of this state-of-the-art manufacturing site.
Initially set up in 2002, the Congers location has seen a considerable transformation, now featuring an extra 28,500 square feet dedicated to warehousing and manufacturing. With a total space of 160,000 square feet, the facility currently employs around 350 team members and operates 14 injection presses, 25 machines, and eight ISO certified clean rooms.
Strategic Global Growth
“This expansion represents a vital advancement in our long-term global growth strategy, which also includes significant investments in injectables in France and the establishment of new manufacturing facilities in Suzhou, China, and Mumbai, India,” Tanda explained. This local expansion is completely in line with Aptar's commitment to a ‘local for local’ model, aimed at effectively meeting the increasing needs of North American pharmaceutical clients.
The Congers site is crucial for producing innovative drug delivery systems. Among its standout products are the proprietary Unidose (UDS) Nasal Spray Systems for the opioid reversal drug naloxone, such as Narcan, and the newly FDA-approved neffy (epinephrine nasal spray), which offers a groundbreaking needle-free solution for emergency allergic reactions.
Innovative Product Development
“We take immense pride in being the go-to partner for drug delivery solutions, converting ideas into market-ready opportunities while speeding up the product development process,” said Gael Touya, President of Aptar Pharma. He noted that the North American division of Aptar has shown impressive growth lately, with a focus on continuous innovation in nasal drug delivery, components for injectables, improving patient experiences, and adopting sustainable practices.
In addition to its array of nasal delivery products, the expanded facility focuses on producing Aptar Pharma’s ETFE PremiumCoat film-coated stoppers for the injectables market. This includes on-site molding and trimming done in a new ISO-7 cleanroom, while finishing and automated vision inspection processes continue in an ISO-5 cleanroom.
About Aptar Pharma
Aptar Pharma operates as a subsidiary of AptarGroup, Inc., a leading global entity in drug and consumer product delivery systems. The company caters to a wide range of markets, including pharmaceuticals, beauty, food and beverage, personal care, and home care products. With its extensive market know-how, creative designs, scientific advancements, and engineering capabilities, Aptar delivers solutions that significantly impact the lives of numerous consumers worldwide. Headquartered in Crystal Lake, Illinois, Aptar employs over 13,000 dedicated professionals across 20 countries.
Frequently Asked Questions
What recent changes have been made by Aptar Pharma?
Aptar Pharma has recently expanded its manufacturing capacity at its Congers, New York facility to meet the growing demand for drug delivery systems.
What types of products does Aptar Pharma produce?
Aptar Pharma produces a variety of drug delivery systems, including nasal spray systems, stoppers for injectables, and solutions for various medical conditions.
Where are Aptar Pharma's manufacturing facilities located?
Aptar Pharma operates globally, with significant manufacturing facilities in locations including the United States, France, Suzhou in China, and Mumbai in India.
How does Aptar Pharma ensure product quality?
The company employs ISO certified clean rooms and adheres to stringent production standards to guarantee the quality of its drug delivery systems.
What markets does Aptar Pharma cater to?
Aptar Pharma serves multiple markets including pharmaceuticals, beauty products, food and beverages, personal care, and home care industries.
